解读STN DBS对帕金森病神经精神疾病波动的影响
Mari Muldmaa1,2,3, Emmanuelle Schmitt1, Roberto Infante1,4
1Grenoble Alpes University, Movement Disorders Unit, CHU of Grenoble, Grenoble Institute of Neuroscience, Grenoble, France.
NPJ Parkinson's disease
|October 27, 2024
概括
脑下核深度大脑刺激 (DBS) 在帕金森病 (PD) 患者中显著减少神经精神学波动. 神经精神病学波动量表 (NFS) 有效地测量了STN-DBS后的这些症状变化.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 神经外科 神经外科
背景情况:
- 神经精神学波动在帕金森病 (PD) 中很常见,影响生活质量.
- 脑下核深度大脑刺激 (STN-DBS) 对这些波动的影响尚不清楚.
- 神经精神病学波动量表 (NFS) 是为了量化这些变化而开发的.
研究的目的:
- 评估双边STN-DBS对PD患者神经精神病学波动的影响.
- 评估STN-DBS在减少这些波动幅度方面的有效性.
主要方法:
- 该研究包括45名接受STN-DBS的PD患者.
- 神经精神病学波动量表 (NFS),包括NFS-plus,NFS-minus,全球和总波动分数 (TFS),在手术前和手术后1年进行.
- 分析了NFS分数的变化,以确定STN-DBS的影响.
主要成果:
- STN-DBS显著降低了神经精神疾病波动的幅度 (p < 0.001).
- NFS有效地捕获了这些药物状态之间的症状波动的减少.
- 无论是高和低多巴胺激素波动都显示了手术后的改善.
结论:
- 双边STN-DBS是一种有效的治疗方法,可以减少帕金森病中神经精神疾病的波动.
- 对于测量STN-DBS对PD神经精神病症状的影响,NFS是一个有价值的工具.
- STN-DBS为管理PD复杂的症状概况提供了显著的好处.
更多相关视频
07:14A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
14.7K
06:32Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
Published on: July 14, 2023
1.2K
相关概念视频
Parkinson's Disease: Treatment
227
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
227
Parkinson's Disease: Overview
486
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
486
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Psychosis: Goals of Pharmacotherapy
104
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
104
